BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31589120)

  • 1. Curcumin - A Novel Therapeutic Agent in the Prevention of Colorectal Cancer.
    Gupta MK; Vadde R; Sarojamma V
    Curr Drug Metab; 2019; 20(12):977-987. PubMed ID: 31589120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo.
    Li M; Yue GG; Tsui SK; Fung KP; Lau CB
    Phytomedicine; 2018 Jul; 46():131-141. PubMed ID: 30097113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Curcumin on the Downregulation of MYC, Insulin and IGF-1 Receptors: A possible Mechanism Underlying the Anti-Growth and Anti-Migration in Chemoresistant Colorectal Cancer Cells.
    Hosseini SA; Zand H; Cheraghpour M
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987250
    [No Abstract]   [Full Text] [Related]  

  • 4. Curcuma as an adjuvant in colorectal cancer treatment.
    Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
    Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic potential of curcumin for colorectal cancer.
    Chauhan DP
    Curr Pharm Des; 2002; 8(19):1695-706. PubMed ID: 12171541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer.
    Calibasi-Kocal G; Pakdemirli A; Bayrak S; Ozupek NM; Sever T; Basbinar Y; Ellidokuz H; Yigitbasi T
    J BUON; 2019; 24(4):1482-1487. PubMed ID: 31646795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
    Sharma RA; McLelland HR; Hill KA; Ireson CR; Euden SA; Manson MM; Pirmohamed M; Marnett LJ; Gescher AJ; Steward WP
    Clin Cancer Res; 2001 Jul; 7(7):1894-900. PubMed ID: 11448902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
    Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
    Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer.
    Marjaneh RM; Rahmani F; Hassanian SM; Rezaei N; Hashemzehi M; Bahrami A; Ariakia F; Fiuji H; Sahebkar A; Avan A; Khazaei M
    J Cell Physiol; 2018 Oct; 233(10):6785-6798. PubMed ID: 29737515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of curcumin action: signal transduction.
    Shehzad A; Lee YS
    Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of Curcuma longa and curcumin on reproductive systems.
    Mohebbati R; Anaeigoudari A; Khazdair MR
    Endocr Regul; 2017 Oct; 51(4):220-228. PubMed ID: 29232190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.
    Megna BW; Carney PR; Depke MG; Nukaya M; McNally J; Larsen L; Rosengren RJ; Kennedy GD
    J Surg Res; 2017 Jun; 213():16-24. PubMed ID: 28601309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-derived anticancer agents - curcumin in cancer prevention and treatment.
    Creţu E; Trifan A; Vasincu A; Miron A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1223-9. PubMed ID: 23700916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin therapeutic promises and bioavailability in colorectal cancer.
    Shehzad A; Khan S; Shehzad O; Lee YS
    Drugs Today (Barc); 2010 Jul; 46(7):523-32. PubMed ID: 20683505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin for chemoprevention of colon cancer.
    Johnson JJ; Mukhtar H
    Cancer Lett; 2007 Oct; 255(2):170-81. PubMed ID: 17448598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future prospective of Curcumin as a potential therapeutic agent in the treatment of colorectal cancer.
    Jalili-Nik M; Soltani A; Moussavi S; Ghayour-Mobarhan M; Ferns GA; Hassanian SM; Avan A
    J Cell Physiol; 2018 Sep; 233(9):6337-6345. PubMed ID: 29219177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.
    Lin HP; Kuo LK; Chuu CP
    Phytother Res; 2012 Jan; 26(1):122-6. PubMed ID: 21567511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytosomal Curcumin Elicits Anti-tumor Properties Through Suppression of Angiogenesis, Cell Proliferation and Induction of Oxidative Stress in Colorectal Cancer.
    Moradi-Marjaneh R; Hassanian SM; Rahmani F; Aghaee-Bakhtiari SH; Avan A; Khazaei M
    Curr Pharm Des; 2018; 24(39):4626-4638. PubMed ID: 30636578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
    Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
    Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New mechanisms and therapeutic potential of curcumin for colorectal cancer.
    Villegas I; Sánchez-Fidalgo S; Alarcón de la Lastra C
    Mol Nutr Food Res; 2008 Sep; 52(9):1040-61. PubMed ID: 18655004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.